Portfolio company
Endogenex
United States · £39.5m raised
Raised
£39.5m
Latest stage
Growth
Rounds recorded
1
Backed by
3 investors
Sectors
About
This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.
SourceFunding history · 1
Similar companies
Digma Medical
This company develops endoscopic laser ablation platforms for gastrointestinal diseases and metabolic conditions for hospitals and specialist medical providers.
DiogenX
This biotech company develops recombinant proteins designed to regenerate insulin-producing pancreatic beta cells for patients with type 1 diabetes.
Encellin
The company develops an encapsulated cell replacement therapy to deliver living medicines for patients with endocrine disorders such as type 1 diabetes.
SynchNeuro
This company develops non-invasive behind-the-ear sensors that decode brain signals to monitor blood glucose and metabolic health for individuals with prediabetes.
Una Health
This company develops personalized digital therapy software and biosensor technology for individuals with type 2 diabetes to manage and reverse metabolic dysfunction.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
Diamontech
This company develops non-invasive laser technology for measuring blood glucose levels without finger pricking for people with diabetes.
EXIMO
This company develops hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications for healthcare providers.
